Institutional members access full text with Ovid®

Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review

Evans, Elizabeth Casiano; Matteson, Kristen A.; Orejuela, Francisco J.; Alperin, Marianna; Balk, Ethan M.; El-Nashar, Sherif; Gleason, Jonathan L.; Grimes, Cara; Jeppson, Peter; Mathews, Cara; Wheeler, Thomas L.; Murphy, Miles; for the Society of Gynecologic Surgeons Systematic Review Group

Obstetrical & Gynecological Survey: April 2017 - Volume 72 - Issue 4 - p 220–221
doi: 10.1097/OGX.0000000000000430
Gynecology: Operative Gynecology

(Abstracted from Obstet Gynecol 2016;128:476–485)

There is a clear survival benefit for prophylactic oophorectomy in patients with inherently higher cancer risk such as those with BRCA1 and BRCA2 and other genetic mutations. For average-risk women, however, cancer risk reduction must be balanced with the consequences of loss of ovarian hormone production and fertility.

University of Texas Health Science Center San Antonio, San Antonio, TX; Women & Infants Hospital, Alpert Medical School of Brown University, and Center for Evidence Based Medicine, Brown University, Providence, RI; Baylor College of Medicine, Houston, TX; University of California, San Diego, San Diego, CA; Case Western Reserve University School of Medicine, Cleveland, OH; Carilion Clinic, Roanoke, VA; Columbia University, College of Physicians and Surgeons, New York, NY; University of New Mexico, Albuquerque, NM; University of South Carolina School of Medicine, Greenville, SC; and Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, PA

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.